A detailed history of Raymond James Financial Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 34,801 shares of TMCI stock, worth $105,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,801
Previous 48,660 28.48%
Holding current value
$105,447
Previous $286,000 18.53%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$5.34 - $7.7 $74,007 - $106,714
-13,859 Reduced 28.48%
34,801 $233,000
Q2 2025

Aug 14, 2025

SELL
$5.44 - $8.32 $142,609 - $218,108
-26,215 Reduced 35.01%
48,660 $286,000
Q1 2025

May 13, 2025

BUY
$7.3 - $10.54 $161,570 - $233,281
22,133 Added 41.96%
74,875 $628,000
Q4 2024

Feb 06, 2025

BUY
$4.66 - $8.78 $245,777 - $463,074
52,742 New
52,742 $392,000

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $168M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.